Senior Director, Strategic Planning and Operations, Germany
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Revolution Medicines is seeking a highly motivated Senior Director, Strategic Planning and Operations to design and lead the German operating model ahead of German and European regulatory milestones, in preparation for future launch readiness. Reporting to the VP, General Manager, Germany, this role drives cross‑functional alignment, owns governance and execution discipline, builds analytics capabilities, strengthens performance management, and ensures operational excellence across all functions in a regulated biotech
